GWAS identifies candidate susceptibility loci and microRNA biomarkers for acute encephalopathy with biphasic seizures and late reduced diffusion

Abstract Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is a severe encephalopathy preceded by viral infections with high fever. AESD is a multifactorial disease, however, few disease susceptibility genes have previously been identified. Here, we conducted a genome-wid...

Full description

Bibliographic Details
Main Authors: Mariko Kasai, Yosuke Omae, Yosuke Kawai, Akiko Shibata, Ai Hoshino, Masashi Mizuguchi, Katsushi Tokunaga
Format: Article
Language:English
Published: Nature Portfolio 2022-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-04576-y
_version_ 1819282293550743552
author Mariko Kasai
Yosuke Omae
Yosuke Kawai
Akiko Shibata
Ai Hoshino
Masashi Mizuguchi
Katsushi Tokunaga
author_facet Mariko Kasai
Yosuke Omae
Yosuke Kawai
Akiko Shibata
Ai Hoshino
Masashi Mizuguchi
Katsushi Tokunaga
author_sort Mariko Kasai
collection DOAJ
description Abstract Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is a severe encephalopathy preceded by viral infections with high fever. AESD is a multifactorial disease, however, few disease susceptibility genes have previously been identified. Here, we conducted a genome-wide association study (GWAS) and assessed functional variants in non-coding regions to study genetic susceptibility in AESD using 254 Japanese children with AESD and 799 adult healthy controls. We also performed a microRNA enrichment analysis using GWAS statistics to search for candidate biomarkers in AESD. The variant with the lowest p-value, rs1850440, was located in the intron of serine/threonine kinase 39 gene (STK39) on chromosome 2q24.3 (p = 2.44 × 10−7, odds ratio = 1.71). The minor allele T of rs1850440 correlated with the stronger expression of STK39 in peripheral blood. This variant possessed enhancer histone modification marks in STK39, the encoded protein of which activates the p38 mitogen-activated protein kinase (MAPK) pathway. In the replication study, the odds ratios of three SNPs, including rs1850440, showed the same direction of association with that in the discovery stage GWAS. One of the candidate microRNAs identified by the microRNA enrichment analysis was associated with inflammatory responses regulated by the MAPK pathway. This study identified STK39 as a novel susceptibility locus of AESD, found microRNAs as potential biomarkers, and implicated immune responses and the MAPK cascade in its pathogenesis.
first_indexed 2024-12-24T01:13:17Z
format Article
id doaj.art-a46b08ff42fc47f5a85fe22302c90f32
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-24T01:13:17Z
publishDate 2022-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-a46b08ff42fc47f5a85fe22302c90f322022-12-21T17:22:50ZengNature PortfolioScientific Reports2045-23222022-01-011211910.1038/s41598-021-04576-yGWAS identifies candidate susceptibility loci and microRNA biomarkers for acute encephalopathy with biphasic seizures and late reduced diffusionMariko Kasai0Yosuke Omae1Yosuke Kawai2Akiko Shibata3Ai Hoshino4Masashi Mizuguchi5Katsushi Tokunaga6Department of Developmental Medical Sciences, Graduate School of Medicine, The University of TokyoGenome Medical Science Project, National Center for Global Health and MedicineGenome Medical Science Project, National Center for Global Health and MedicineDepartment of Developmental Medical Sciences, Graduate School of Medicine, The University of TokyoDepartment of Developmental Medical Sciences, Graduate School of Medicine, The University of TokyoDepartment of Developmental Medical Sciences, Graduate School of Medicine, The University of TokyoGenome Medical Science Project, National Center for Global Health and MedicineAbstract Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is a severe encephalopathy preceded by viral infections with high fever. AESD is a multifactorial disease, however, few disease susceptibility genes have previously been identified. Here, we conducted a genome-wide association study (GWAS) and assessed functional variants in non-coding regions to study genetic susceptibility in AESD using 254 Japanese children with AESD and 799 adult healthy controls. We also performed a microRNA enrichment analysis using GWAS statistics to search for candidate biomarkers in AESD. The variant with the lowest p-value, rs1850440, was located in the intron of serine/threonine kinase 39 gene (STK39) on chromosome 2q24.3 (p = 2.44 × 10−7, odds ratio = 1.71). The minor allele T of rs1850440 correlated with the stronger expression of STK39 in peripheral blood. This variant possessed enhancer histone modification marks in STK39, the encoded protein of which activates the p38 mitogen-activated protein kinase (MAPK) pathway. In the replication study, the odds ratios of three SNPs, including rs1850440, showed the same direction of association with that in the discovery stage GWAS. One of the candidate microRNAs identified by the microRNA enrichment analysis was associated with inflammatory responses regulated by the MAPK pathway. This study identified STK39 as a novel susceptibility locus of AESD, found microRNAs as potential biomarkers, and implicated immune responses and the MAPK cascade in its pathogenesis.https://doi.org/10.1038/s41598-021-04576-y
spellingShingle Mariko Kasai
Yosuke Omae
Yosuke Kawai
Akiko Shibata
Ai Hoshino
Masashi Mizuguchi
Katsushi Tokunaga
GWAS identifies candidate susceptibility loci and microRNA biomarkers for acute encephalopathy with biphasic seizures and late reduced diffusion
Scientific Reports
title GWAS identifies candidate susceptibility loci and microRNA biomarkers for acute encephalopathy with biphasic seizures and late reduced diffusion
title_full GWAS identifies candidate susceptibility loci and microRNA biomarkers for acute encephalopathy with biphasic seizures and late reduced diffusion
title_fullStr GWAS identifies candidate susceptibility loci and microRNA biomarkers for acute encephalopathy with biphasic seizures and late reduced diffusion
title_full_unstemmed GWAS identifies candidate susceptibility loci and microRNA biomarkers for acute encephalopathy with biphasic seizures and late reduced diffusion
title_short GWAS identifies candidate susceptibility loci and microRNA biomarkers for acute encephalopathy with biphasic seizures and late reduced diffusion
title_sort gwas identifies candidate susceptibility loci and microrna biomarkers for acute encephalopathy with biphasic seizures and late reduced diffusion
url https://doi.org/10.1038/s41598-021-04576-y
work_keys_str_mv AT marikokasai gwasidentifiescandidatesusceptibilitylociandmicrornabiomarkersforacuteencephalopathywithbiphasicseizuresandlatereduceddiffusion
AT yosukeomae gwasidentifiescandidatesusceptibilitylociandmicrornabiomarkersforacuteencephalopathywithbiphasicseizuresandlatereduceddiffusion
AT yosukekawai gwasidentifiescandidatesusceptibilitylociandmicrornabiomarkersforacuteencephalopathywithbiphasicseizuresandlatereduceddiffusion
AT akikoshibata gwasidentifiescandidatesusceptibilitylociandmicrornabiomarkersforacuteencephalopathywithbiphasicseizuresandlatereduceddiffusion
AT aihoshino gwasidentifiescandidatesusceptibilitylociandmicrornabiomarkersforacuteencephalopathywithbiphasicseizuresandlatereduceddiffusion
AT masashimizuguchi gwasidentifiescandidatesusceptibilitylociandmicrornabiomarkersforacuteencephalopathywithbiphasicseizuresandlatereduceddiffusion
AT katsushitokunaga gwasidentifiescandidatesusceptibilitylociandmicrornabiomarkersforacuteencephalopathywithbiphasicseizuresandlatereduceddiffusion